- Nachrichtendetail
-
09.04.2024 12:50:53 - dpa-AFX: *PFIZER SAYS PHASE 3 ABRYSVO STUDY MEETS TRIAL PRIMARY ENDPOINTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Pfizer | 852009 | NYSE | 28,270 | 14.05.24 20:18:53 | -0,170 | -0,60% | 28,260 | 28,270 | 28,550 | 28,440 |
